About 69,000 new cases and nearly 14,000 deaths are expected this year, according to the American Cancer Society.

CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...

In the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...

Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...

A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Two growth stocks in the healthcare industry stand out in particular. Here is what you need to know about each one and why ...

Ryan Seacrest Sparks Concern From Fans in New Photos originally appeared on Parade. Ryan Seacrest has fans worried after the Wheel of Fortune host shared some new photos via social media.

"Employers have absorbed the majority of cost increases over the past four years, and they likely cannot continue to do so," ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the drugmaker in a more vulnerable position when rival Eli Lilly ...

Taylor Fritz blames opponent for Wimbledon curfew controversy after match suspended Senate Republican tax bill passes ‘SALT’ ...